Response to: 'Comment on: ‘Dupilumab-associated ocular surface disease: presentation, management and long-term sequelae’ (original) (raw)

Academia.edu no longer supports Internet Explorer.

To browse Academia.edu and the wider internet faster and more securely, please take a few seconds to upgrade your browser.